Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Gili Halfteck

Concepts (60)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
3
2024
1205
0.660
Why?
Gallbladder Neoplasms
1
2019
7
0.620
Why?
Adenoma
1
2019
113
0.560
Why?
Adenocarcinoma
1
2019
404
0.460
Why?
Neoplasm Invasiveness
2
2024
278
0.350
Why?
Natural Cytotoxicity Triggering Receptor 1
1
2009
5
0.310
Why?
Antigens, Ly
1
2009
8
0.310
Why?
Cytotoxicity, Immunologic
1
2009
57
0.300
Why?
Killer Cells, Natural
1
2009
115
0.290
Why?
Lymphoma
1
2009
71
0.290
Why?
Laparoscopy
2
2022
181
0.260
Why?
Mastectomy
2
2023
143
0.240
Why?
Retrospective Studies
6
2024
6662
0.230
Why?
Parathyroid Neoplasms
1
2024
27
0.220
Why?
Axilla
1
2024
92
0.220
Why?
Neoplasm Staging
2
2024
767
0.220
Why?
Neoplasm Recurrence, Local
3
2024
642
0.220
Why?
Sentinel Lymph Node Biopsy
1
2024
118
0.210
Why?
Radiotherapy, Adjuvant
1
2023
64
0.210
Why?
Lymph Node Excision
1
2024
133
0.210
Why?
Neoadjuvant Therapy
1
2024
125
0.200
Why?
Intestinal Fistula
1
2022
9
0.190
Why?
Mammaplasty
1
2022
43
0.180
Why?
Lymph Nodes
1
2023
252
0.180
Why?
Crohn Disease
1
2022
114
0.170
Why?
Prospective Studies
1
2023
2453
0.140
Why?
Infant, Newborn
1
2023
2884
0.120
Why?
Cushing Syndrome
1
2014
9
0.110
Why?
Adrenalectomy
1
2014
31
0.110
Why?
Adrenal Glands
1
2014
39
0.110
Why?
Pheochromocytoma
1
2014
35
0.110
Why?
Adrenal Gland Neoplasms
1
2014
49
0.110
Why?
Female
6
2024
28236
0.100
Why?
Humans
7
2024
52539
0.100
Why?
Postoperative Complications
2
2022
1081
0.100
Why?
Survival Rate
2
2024
953
0.090
Why?
Follow-Up Studies
2
2024
2293
0.080
Why?
Flow Cytometry
1
2009
400
0.070
Why?
Mice, Knockout
1
2009
910
0.060
Why?
Parathyroidectomy
1
2024
46
0.050
Why?
Chemotherapy, Adjuvant
1
2024
124
0.050
Why?
Lymphatic Metastasis
1
2024
211
0.050
Why?
Adult
3
2024
14160
0.050
Why?
Middle Aged
3
2024
13094
0.050
Why?
Ileum
1
2022
88
0.050
Why?
Colon
1
2022
105
0.050
Why?
Insurance Coverage
1
2022
115
0.040
Why?
Aged
2
2024
10197
0.040
Why?
Prognosis
1
2024
2116
0.040
Why?
Prevalence
1
2022
1017
0.040
Why?
Mice
1
2009
5944
0.040
Why?
Treatment Outcome
2
2022
5484
0.040
Why?
Healthcare Disparities
1
2022
300
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1030
0.040
Why?
Male
3
2024
26831
0.030
Why?
Israel
1
2014
10
0.030
Why?
Comparative Effectiveness Research
1
2014
47
0.030
Why?
Neoplasm Metastasis
1
2014
238
0.030
Why?
Animals
1
2009
13465
0.030
Why?
Reproducibility of Results
1
2014
1216
0.020
Why?
Halfteck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_